Kenyan e-health startup MYDAWA has secured an undisclosed amount of funding round to accelerate its mission of expanding healthcare access.
Founded in 2017, MYDAWA is a technology-driven digital health company delivering holistic healthcare solutions across Kenya and Uganda. Its integrated platform offers online doctor consultations, lab testing, e-prescriptions, chronic-care management and medication delivery.
The funding round features IFU, Alta Semper, AAIC Investment, Creadev and Ohara Pharmaceutical Co, and will enable MYDAWA to scale its “Bricks-and-Clicks Super Pharmacy” model across new markets, enhance chronic-disease support programmes for patients who need regular, affordable care, and integrate AI-driven features to streamline service delivery, optimise inventory management, and ultimately reduce costs for patients.
“The calibre of investors joining this round speaks for itself,” said Neil O’Leary, MYDAWA’s founder. “It confirms that MYDAWA is not just solving real problems at scale – it’s building a blueprint for the future of healthcare in Africa. We’re honoured to have partners who share our vision and will help us accelerate our mission.”
“As MYDAWA’s long-term partner, we’ve witnessed firsthand the company’s ability to deliver transformative healthcare solutions at scale,” said Zach Fond, partner at Alta Semper. “We’re excited to see this next phase of growth, which reinforces MYDAWA’s position as a category leader and a blueprint for digital health innovation across Africa.”
